JPS6422853A - Nucleoside analog - Google Patents

Nucleoside analog

Info

Publication number
JPS6422853A
JPS6422853A JP17723487A JP17723487A JPS6422853A JP S6422853 A JPS6422853 A JP S6422853A JP 17723487 A JP17723487 A JP 17723487A JP 17723487 A JP17723487 A JP 17723487A JP S6422853 A JPS6422853 A JP S6422853A
Authority
JP
Japan
Prior art keywords
adenine
amino
compound
formula
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP17723487A
Other languages
Japanese (ja)
Inventor
Yasushi Matsumura
Yoshitomi Morisawa
Arata Yasuda
Keiichi Uchida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGC Inc
Original Assignee
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Glass Co Ltd filed Critical Asahi Glass Co Ltd
Priority to JP17723487A priority Critical patent/JPS6422853A/en
Publication of JPS6422853A publication Critical patent/JPS6422853A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pyridine Compounds (AREA)

Abstract

NEW MATERIAL:A compound of the formula (B is residue of nucleic acid base). EXAMPLE:9-[2,3-Dideoxy-4a-(hydroxymethyl)-2-cyclopentene-1a-yl]adenine. USE:Antitumor agent, antiviral or agrochemicals. PREPARATION:For example, in the preparation of adenosine, the reaction of 5-amino-4,6-dichloropyrimidine with cis-4-amino-2-cyclopentanemethanol gives a diaminopyrimidine derivative, then ethyl orthoformate is used to form the purine skeleton, further the chlorine atom in the 6-position of the purine ring is treated with ammonia to convert into adenine to give the compound of the formula.
JP17723487A 1987-07-17 1987-07-17 Nucleoside analog Pending JPS6422853A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17723487A JPS6422853A (en) 1987-07-17 1987-07-17 Nucleoside analog

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17723487A JPS6422853A (en) 1987-07-17 1987-07-17 Nucleoside analog

Publications (1)

Publication Number Publication Date
JPS6422853A true JPS6422853A (en) 1989-01-25

Family

ID=16027498

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17723487A Pending JPS6422853A (en) 1987-07-17 1987-07-17 Nucleoside analog

Country Status (1)

Country Link
JP (1) JPS6422853A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0349242A2 (en) * 1988-06-27 1990-01-03 The Wellcome Foundation Limited Therapeutic nucleosides
WO1991015490A1 (en) * 1990-04-06 1991-10-17 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
WO1991015489A1 (en) * 1990-04-06 1991-10-17 Glaxo Inc. Process for the synthesis of cyclopentene derivatives
US5922694A (en) * 1988-01-20 1999-07-13 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
JP2008515962A (en) * 2004-10-12 2008-05-15 グレンマーク・ファーマシューティカルズ・エスエー Novel dipeptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and processes for preparing them

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922694A (en) * 1988-01-20 1999-07-13 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US5962684A (en) * 1988-01-20 1999-10-05 Regents Of The University Of Minnesota Method of preparation of dideoxycarbocyclic nucleosides
US6072053A (en) * 1988-01-20 2000-06-06 Univ Minnesota Dideoxycarbocyclic nucleosides
EP0349242A2 (en) * 1988-06-27 1990-01-03 The Wellcome Foundation Limited Therapeutic nucleosides
US5034394A (en) * 1988-06-27 1991-07-23 Burroughs Wellcome Co. Therapeutic nucleosides
US5049671A (en) * 1988-06-27 1991-09-17 Burroughs Wellcome Co. 6-substituted purine carbocyclic nucleosides
WO1991015490A1 (en) * 1990-04-06 1991-10-17 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
WO1991015489A1 (en) * 1990-04-06 1991-10-17 Glaxo Inc. Process for the synthesis of cyclopentene derivatives
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5144034A (en) * 1990-04-06 1992-09-01 Glaxo Inc. Process for the synthesis of cyclopentene derivatives of purines
JP2008515962A (en) * 2004-10-12 2008-05-15 グレンマーク・ファーマシューティカルズ・エスエー Novel dipeptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and processes for preparing them

Similar Documents

Publication Publication Date Title
MY121839A (en) Antiviral purine derivatives
UA29382C2 (en) 6-substituted purine carbocyclic nucleosides
IL98702A (en) 9-purinyl phosphonic acid derivatives their preparation and pharmaceutical compositions containing them
NO975585L (en) C-4 'modified adenosine kinase inhibitors
TW341574B (en) METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings.
Elion et al. Biological activities of some purine arabinosides
DE3264465D1 (en) 7-beta-d-arabinofuranosyl-7h-pyrrolo(2,3-d)pyrimidine-4-amine 5'-phosphate compounds useful as antiviral agents, pharmaceutical compositions containing the compounds, and processes for producing the compounds
US3817978A (en) 4-fluoro nucleosides and sugar intermediates, and methods of preparing
GR3026166T3 (en) Conformationally locked nucleoside analogues
ATE131826T1 (en) ANTI-HIV PYRIMIDINE NUCLEOSIDE
JPS6422853A (en) Nucleoside analog
DE3580169D1 (en) METHOD FOR PRODUCING 2,6-SUBSTITUTED 9- (1,3-DIHYDROXY-2-PROPOXYMETHYL) PURINES AND SOME DERIVATIVES.
NO932287L (en) 2'-deosky-2 ', 2'-difluoro (2,6,8-substituted) purine nucleosides with antiviral anticancer activity, and intermediates
IL138288A (en) 2-amino-9-[bisetherified 4-hydroxy-3-(hydroxymethyl) butyl] purine derivatives, process for the production thereof, intermediates therefor and their use as starting materials for the preparation of antiviral purines
WO1990009177A1 (en) Cyclopentenyl pyrimidines and methods of using same
GB975850A (en) Xanthine oxidase inhibitors
Jähne et al. Preparation of carbocyclic phosphonate nucleosides
Hecht et al. Competitive inhibition of beef heart cyclic AMP phosphodiesterase by cytokinins and related compounds
ES2013379A6 (en) Antitumor 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides and related compounds
EP0391411A3 (en) 3'-substituted methyl nucleosides as antiviral agents
EP0330992A3 (en) Novel cyclobutane derivatives, processes for their preparation and pharmaceutical compositions comprising them
Herdewijn et al. Synthesis of Pyranose Nucleosides
Boryski et al. Transglycosylation of guanine nucleosides
Harnden et al. Synthesis of 9-hydroxypurines: Intermediates to novel antiviral acyclonucleosides
JPS6429394A (en) Purine nucleoside derivative